Page 20 - IJB-9-3
P. 20

International Journal of Bioprinting                         Bioprinting of PDAC microtissues for drug screening


               https://doi.org/10.18063/ijb.v7i4.444              https://doi.org/10.1186/s13046-019-1153-8
            19.  Antunes J, Gaspar VM, Ferreira L,  et al., 2019, In-air   30.  Rimal R, Desai P, Daware R, et al., 2022, Cancer-associated
               production of 3D co-culture tumor spheroid hydrogels for   fibroblasts:  Origin,  function,  imaging,  and  therapeutic
               expedited drug screening. Acta Biomater, 94: 392–409.   targeting. Adv Drug Deliv Rev, 189: 114504.
               https://doi.org/10.1016/j.actbio.2019.06.012       https://doi.org/10.1016/j.addr.2022.114504
            20.  Monteiro MV, Gaspar VM, Mendes L, et al., 2021, Stratified   31.  Han CC, Liu TY, Yin R, 2020, Biomarkers for cancer-
               3D microtumors as organotypic testing platforms for   associated fibroblasts. Biomark Res, 8: 64.
               screening pancreatic cancer therapies.  Small Methods,
               5: 2001207.                                        https://doi.org/10.1186/s40364-020-00245-w
                                                               32.  Lee JH, Kim SK, Khawar IA,  et al., 2018, Microfluidic
               https://doi.org/10.1002/smtd.202001207
                                                                  co-culture of pancreatic tumor spheroids with stellate cells
            21.  Monteiro MV, Rocha M, Gaspar VM,  et al., 2022,   as a novel 3D model for investigation of stroma-mediated
               Programmable living units for emulating pancreatic tumor-  cell motility and drug resistance. J Exp Clin Canc Res, 37: 4.
               stroma interplay. Adv Healthc Mater, 11: e2102574.
                                                                  https://doi.org/10.1186/s13046-017-0654-6
               https://doi.org/10.1002/adhm.202102574
                                                               33.  Mehrpouya M, Pourhashem Z, Yardehnavi N, et al., 2019,
            22.  Murphy SV, De Coppi P, Atala A, 2020, Opportunities and   Evaluation of cytokeratin 19 as a prognostic tumoral and
               challenges of translational 3D bioprinting. Nat Biomed Eng,   metastatic marker with focus on improved detection
               4: 370–80.                                         methods. J Cell Physiol, 234: 21425–21435.
               https://doi.org/10.1038/s41551-019-0471-7          https://doi.org/10.1002/jcp.28768
            23.  Ayan B, Heo DN, Zhang Z, et al., 2020, Aspiration-assisted   34.  Von Ahrens D, Bhagat TD, Nagrath D, et al., 2017, The role
               bioprinting for precise positioning of biologics. Sci Adv, 6:   of stromal cancer-associated fibroblasts in pancreatic cancer.
               eaaw5111.                                          J Hematol Oncol, 10: 76.
               https://doi.org/10.1126/sciadv.aaw5111             https://doi.org/10.1186/s13045-017-0448-5
            24.  Matai  I, Kaur  G, Seyedsalehi  A,  et al., 2020,  Progress  in   35.  Ligorio  M,  Sil  S,  Malagon-Lopez  J,  et  al.,  2019,  Stromal
               3D bioprinting technology for tissue/organ regenerative   microenvironment shapes the intratumoral architecture of
               engineering. Biomaterials, 226: 119536.            pancreatic cancer. Cell, 178: 160–175.
               https://doi.org/10.1016/j.biomaterials.2019.119536     https://doi.org/10.1016/j.cell.2019.05.012
            25.  Xie MJ, Gao Q, Zhao HM,  et al., 2019, Electro-assisted   36.  Ware MJ, Keshishian V, Law JJ, et al., 2016, Generation of an
               bioprinting of low-concentration GelMA microdroplets.   in vitro 3D PDAC stroma rich spheroid model. Biomaterials,
               Small, 15: 1804216.                                108: 129–142.
               https://doi.org/10.1002/smll.201804216             https://doi.org/10.1016/j.biomaterials.2016.08.041
            26.  Clua-Ferré L, De Chiara F, Rodríguez-Comas J, et al., 2022,   37.  Berlin J, Benson AB 3 , 2010, Gemcitabine remains the
                                                                                    rd
               Collagen-tannic acid spheroids for  β-cell encapsulation   standard of care for pancreatic cancer. Nat Rev Clin Oncol,
               fabricated using a 3D bioprinter.  Adv Mater Technol-US,   7: 135–137.
               7: 2101696.
                                                                  https://doi.org/10.1038/nrclinonc.2010.16
               https://doi.org/10.1002/admt.202101696
                                                               38.  Liu HQ, Shi Y, Qian F, 2021, Opportunities and delusions
            27.  Vennin C, Murphy KJ, Morton JP, et al., 2018, Reshaping   regarding drug delivery targeting pancreatic cancer-
               the tumor stroma for treatment of pancreatic cancer.   associated fibroblasts. Adv Drug Deliv Rev, 172: 37–51.
               Gastroenterology, 154: 820–838.
                                                                  https://doi.org/10.1016/j.addr.2021.02.012
               https://doi.org/10.1053/j.gastro.2017.11.280
                                                               39.  Benton G, Arnaoutova I, George J,  et al., 2014, Matrigel:
            28.  Rubiano A, Delitto D, Han S,  et  al., 2018, Viscoelastic
               properties of human pancreatic tumors and  in vitro   From discovery and ECM mimicry to assays and models for
               constructs to mimic mechanical properties. Acta Biomater,   cancer research. Adv Drug Deliv Rev, 79-80: 3–18.
               67: 331–340.                                       https://doi.org/10.1016/j.addr.2014.06.005
               https://doi.org/10.1016/j.actbio.2017.11.037    40.  Liu HY, Korc M, Lin CC, 2018, Biomimetic and enzyme-
                                                                  responsive dynamic hydrogels for studying cell-matrix
            29.  Looi CK, Chung FF, Leong CO,  et  al., 2019, Therapeutic
               challenges and current immunomodulatory strategies   interactions in pancreatic ductal adenocarcinoma.
               in targeting the immunosuppressive pancreatic tumor   Biomaterials, 160: 24–36.
               microenvironment. J Exp Clin Canc Res, 38: 162.      https://doi.org/10.1016/j.biomaterials.2018.01.012


            Volume 9 Issue 3 (2023)                         12                      https://doi.org/10.18063/ijb.v9i3.676
   15   16   17   18   19   20   21   22   23   24   25